Diamond Comics Distributors has released its initial sales rankings for last month, which show Marvel Comics had an incredibly strong showing in October. The publisher lead the month in both dollar and unit share in no small thanks to the strong performance of Rick Remender and John Cassaday's "Uncanny Avengers" #1, the leading single issue in the top ten. Another major factor in Marvel's strong performance was no doubt the conclusion to its "Avengers Vs. X-Men" mega-event, which paved the way for its Marvel NOW! publishing initiative. "Avengers Vs. X-Men" #12 was second for the month, while "A Plus X" #1, "AVX VS" #6 and "AVX: Consequences" #1 also found their way onto the top ten list.
However, while Marvel may have taken the single issue chart by storm, it was DC Comics that was most prevalent in the graphic novel and trade paperbacks top ten. In addition to four major titles in the top ten single issues, "Superman: Earth One Volume 2" led the top trades, with "Batman: The Dark Knight," "Batman," "Nightwing" and "V For Vendetta" dominating the latter half of the ten bestselling October graphic novels.
Image Comics' "The Walking Dead" continues a very strong performance in the direct market with "The Walking Dead" #103 as the only non-Marvel or DC single issue to make the top ten in October. Image dominated the top five graphic novels and trade paperbacks with "Saga" Volume 1 leading the way at #2, followed closely by "The Walking Dead" Compendium Volume 2 and the first two trade paperbacks of Robert Kirkman's popular undead saga.
Both dollar and unit share were up nearly five percent from September and nearly 17 percent compared to October 2011. Sales both in dollars and units year-to-date compared with 2011 show marked improvement.
Check out the sales numbers below and stay tuned to CBR News for more detailed analysis of Diamond's October sales numbers.
PUBLISHER | DOLLAR SHARE | UNIT SHARE |
MARVEL COMICS | 35.14% | 39.54% |
DC COMICS | 31.51% | 34.40% |
IMAGE COMICS | 8.47% | 7.60% |
IDW PUBLISHING | 4.62% | 3.82% |
DARK HORSE COMICS | 3.81% | 3.11% |
DYNAMITE ENTERTAINMENT | 2.71% | 2.78% |
BOOM! STUDIOS | 1.29% | 1.39% |
AVATAR PRESS INC | 1.26% | 1.04% |
RANDOM HOUSE | 1.19% | 0.25% |
ZENESCOPE ENTERTAINMENT INC | 1.03% | 1.03% |
OTHER NON-TOP 10 | 8.96% | 5.04% |
DOLLARS | UNITS | |
OCTOBER 2012 VS. SEPTEMBER 2012 | ||
COMICS | 20.02% | 16.15% |
GRAPHIC NOVELS | 24.41% | 13.11% |
TOTAL COMICS/GN | 21.45% | 15.90% |
OCTOBER 2012 VS. OCTOBER 2011 | ||
COMICS | 7.44% | -0.82% |
GRAPHIC NOVELS | 53.87% | 52.85% |
TOTAL COMICS/GN | 19.50% | 2.11% |
YEAR-TO-DATE 2012 VS. YEAR-TO-DATE 2011 | ||
COMICS | 15.89% | 12.31% |
GRAPHIC NOVELS | 17.97% | 17.10% |
TOTAL COMICS/GN | 16.55% | 12.68% |
RANK | DESCRIPTION | PRICE | ITEM CODE | VENDOR |
1 | UNCANNY AVENGERS #1 | $3.99 | AUG120550 | MAR |
2 | AVENGERS VS. X-MEN #12 | $4.99 | JUL120535 | MAR |
3 | BATMAN #13 | $3.99 | AUG120180 | DC |
4 | JUSTICE LEAGUE #13 | $3.99 | AUG120146 | DC |
5 | A PLUS X #1 | $3.99 | AUG120562 | MAR |
6 | GREEN LANTERN #13 | $2.99 | AUG120199 | DC |
7 | DETECTIVE COMICS #13 | $3.99 | AUG120184 | DC |
8 | AVX VS. #6 | $3.99 | JUL120526 | MAR |
9 | WALKING DEAD #103 (MR) | $2.99 | AUG120472 | IMA |
10 | AVX: CONSEQUENCES #1 | $3.99 | AUG120569 | MAR |
RANK | DESCRIPTION | PRICE | ITEM CODE | VENDOR |
1 | SUPERMAN: EARTH ONE VOLUME 2 HC | $22.99 | JUN120225 | DC |
2 | SAGA VOLUME 1 TP | $9.99 | AUG120491 | IMA |
3 | THE WALKING DEAD COMPENDIUM VOL. 2 TP | $59.99 | AUG120496 | IMA |
4 | THE WALKING DEAD VOL. 1: DAYS GONE BYE TP | $9.99 | JUL068351 | IMA |
5 | THE WALKING DEAD VOL. 2: MILES BEHIND US TP | $14.99 | SEP088204 | IMA |
6 | BATMAN: THE DARK KNIGHT VOLUME 1: KNIGHT TERRORS HC | $24.99 | JUN120234 | DC |
7 | DEADPOOL KILLS THE MARVEL UNIVERSE TP | $14.99 | AUG120709 | MAR |
8 | NIGHTWING VOL. 1: TRAPS AND TRAPEZES TP | $14.99 | JUL120214 | DC |
9 | V FOR VENDETTA: BOOK AND MASK SET | $24.99 | JUN120291 | DC |
10 | BATMAN VOL. 1: THE COURT OF OWLS HC | $24.99 | JAN120300 | DC |
Discuss this story in CBR's Community Forum forum. | 12 Comments
|
|
Follow @cbr | Tweet |


